OpGen Acquires iCapX Parent Company for $12.3 Million in Stock Deal

Reuters01-17
OpGen Acquires iCapX Parent Company for $12.3 Million in Stock Deal

OpGen, Inc. has completed the acquisition of all issued and outstanding shares of Sun Investment Enterprises Limited from AEI Capital Ltd. As a result, OpGen now indirectly owns iCapX Sdn. Bhd., a Malaysian fintech company that provides cap table management and corporate advisory services. The purchase price of $12,278,703.08 was paid through the issuance of 2,028,867 shares of OpGen common stock at $6.052 per share. Following the acquisition, iCapX fulfilled a corporate advisory agreement for a client, receiving an $80,000 fee and 1.4% of the client’s outstanding equity, valued at approximately $14 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OpGen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-000370), on January 16, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment